OOIR: Observatory of International Research

Papers

(The TQCC of Pharmacological Reviews is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)

Article	Citations
Table of Contents	584
Table of Contents	390
How to drug a cloud? Targeting intrinsically disordered proteins	255
The pharmacology of vitamin C	232
Editorial Board	194
Editorial Board	125
Editorial Board	122
Correction to “Sex- and Gender-Based Pharmacological Response to Drugs”	114
Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review	109
Inhaled β2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?	97
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview	95
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease	86
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update	84
Pharmacology of Hydrogen Sulfide and Its Donors in Cardiometabolic Diseases	82
Topically Applied Therapies for the Treatment of Skin Disease: Past, Present, and Future	79
Editorial Board	72
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies	71
Editorial Board	71
Hope on the Horizon: Promising Therapies for Steatotic Liver Disease	71
A Chance to Grow and Excel as an Associate Editor of Pharmacological Reviews—Editorial	69
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies	69
Modeling Pharmacokinetic Natural Product–Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach	66
A 25-Year Journey as Author and Associate Editor of Pharmacological Reviews—Editorial	66
Understanding the Neural Mechanisms of General Anesthesia from Interaction with Sleep–Wake State: A Decade of Discovery	63
Safety in treatment: Classical pharmacotherapeutics and new avenues for addressing maternal depression and anxiety during pregnancy	62

Seventy-Five Years of Interactions: The Department of Physiology and Pharmacology at Karolinska Institutet and Pharmacological Reviews	61
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials	54
Analgesic Potential of Terpenes Derived from Cannabis sativa	53
Brain Cancer Drug Discovery: Clinical Trials, Drug Classes, Targets, and Combinatorial Therapies	53
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4	52
Neurobiological Mechanisms of Nicotine Reward and Aversion	51
The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes	50
Extracellular Vesicle Heterogeneity and Its Impact for Regenerative Medicine Applications	50
Pharmacological Reviews’ 75th Year Anniversary: Past and Future—Editorial	49
Looking Under the Lamppost: The Search for New Cancer Targets in the Human Kinome	46
Biochemistry, pharmacology, and in vivo function of arginases	45
Multi- and polypharmacology of carbonic anhydrase inhibitors	45
Pharmacologic treatments for gastroparesis	44
Organic anion transporting polypeptides: Pharmacology, toxicology, structure, and transport mechanisms	42
Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis	37
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin	37
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain	37
Conotoxins Targeting Voltage-Gated Sodium Ion Channels	36
Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions	36
Review of Natural Language Processing in Pharmacology	36
Ironing Out the Mechanism of gp130 Signaling	35
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting	33
The 75-Year Anniversary of the Department of Physiology and Pharmacology at Karolinska Institutet—Examples of Recent Accomplishments and Future Perspectives	33
Molecular Pathways Governing the Termination of Liver Regeneration	33
Animal Behavior in Psychedelic Research	31
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target	31
A Commitment to Excellence from the New Editor	28
Editorial Board	28
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications	28
New Aspects of Diabetes Research and Therapeutic Development	26
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications	26
Correction to “Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments”	25
Editorial Board	25
L-Type Calcium Channel Blockers: A Potential Novel Therapeutic Approach to Drug Dependence	25
Bioactives from marine resources as natural health products: A review	25